Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:57:31.101Z.
Calculation as of: 2026-10-06T16:57:31.101Z.
Quote observation: 2026-10-06T16:55:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 55b8dbabd3995de6814355fb2a21bc992d842325745fe4a48a34f8d646fc1b47
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$4.67B
EV/EBIT Ratio
59.24x
TTM Avg
192.46x
3Y Avg
192.46x
5Y Avg
192.46x
Market Cap
$4.66B
EV/EBIT Ratio
16.94x
TTM Avg
15.96x
3Y Avg
18.18x
5Y Avg
22.57x
Market Cap
$4.63B
EV/EBIT Ratio
97.51x
TTM Avg
157.20x
3Y Avg
157.20x
5Y Avg
157.20x
Market Cap
$5.07B
EV/EBIT Ratio
27.04x
TTM Avg
27.45x
3Y Avg
34.84x
5Y Avg
44.16x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.85B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.82B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.67B | 59.24x | 192.46x | 192.46x | 192.46x |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | N/A | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 16.94x | 15.96x | 18.18x | 22.57x |
| BillionToOne, Inc. (BLLN)vs › | $4.63B | 97.51x | 157.20x | 157.20x | 157.20x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 27.04x | 27.45x | 34.84x | 44.16x |
| Erasca, Inc. (ERAS)vs › | $5.08B | N/A | N/A | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.10B | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
